The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current EPS (TTM) is ยฃ10.67. In 2022 the company made an earnings per share (EPS) of ยฃ9.18 an increase over its 2021 EPS that were of ยฃ7.81.
Year | EPS | Change |
---|---|---|
2023 (TTM) | ยฃ11.48 | 25.07% |
2022 | ยฃ9.18 | 17.57% |
2021 | ยฃ7.81 | -16.38% |
2020 | ยฃ9.34 | -4.32% |
2019 | ยฃ9.76 | 2.05% |
2018 | ยฃ9.57 | 382.51% |
2017 | ยฃ1.98 | -74.52% |
2016 | ยฃ7.78 | 12.66% |
2015 | ยฃ6.91 | 34.9% |
2014 | ยฃ5.12 | 0.74% |
2013 | ยฃ5.08 | 20.36% |
2012 | ยฃ4.22 | 37.93% |
2011 | ยฃ3.06 | -15.77% |
2010 | ยฃ3.63 | 6.4% |
2009 | ยฃ3.42 | 19.84% |
2008 | ยฃ2.85 | 35% |
2007 | ยฃ2.11 | 12% |
2006 | ยฃ1.88 | -15.54% |
2005 | ยฃ2.23 | 59.14% |
2004 | ยฃ1.40 | 6.9% |
2003 | ยฃ1.31 | -289.13% |
2002 | -ยฃ0.69 | -186.79% |
2001 | ยฃ0.80 | -4.5% |
2000 | ยฃ0.84 | 4.72% |
1999 | ยฃ0.80 | 23.98% |
1998 | ยฃ0.64 | 40.16% |
1997 | ยฃ0.46 | 2.52% |
1996 | ยฃ0.45 |